Credit: University of Nottingham

Family-led rehabilitation is not effective in aiding the recovery of people who have suffered a stroke, a major international trial involving researchers at the University of Nottingham has suggested.

The results of the study, which was run across 13 centres throughout India and was one of the largest stroke rehabilitation trials ever undertaken, have surprised the researchers who led the work.

The research, published in The Lancet, revealed that there was no reduction in disability for patients on the trial, compared to those who received no extra care.

Professor Marion Walker, in the University's School of Medicine, was part of the team which conducted the study. She said: "The ATTEND trial was the largest global stroke rehabilitation trial ever to have been conducted and pulled together an impressive team of world-leading stroke researchers.

"It is estimated that around 1.6 million people have a stroke in India each year, yet the vast majority receive little or no formal rehabilitation. Stroke in India affects a much younger population than in (on average 15 years younger) which can have a significant impact on an individual's ability to return to work and generate income.

"Our intervention ensured were trained by experts to deliver rehabilitation within the home environment, thereby ensuring patients received much more rehabilitation training than they would normally have received in routine practice.

"Given the limited resources available to stroke survivors in India, we felt this was a hugely important study and were surprised by the results. We now need to find alternative ways of ensuring in India make an optimal recovery."

The results raise serious questions about the benefit of rehabilitation carried out by family members and highlights the need for urgent investment in professional facilities in low and .

More information: R I Lindley et al. Family-led rehabilitation after stroke in India (ATTEND): a randomised controlled trial, The Lancet (2017). DOI: 10.1016/S0140-6736(17)31447-2

Journal information: The Lancet